N-(2-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PENTANAMIDE, 95%, 250mg

Cobalt(II) bromide Anhydrous, 98.0%, 100g

2,3-Diaminobenzamide dihydrochloride, 95+%, 10g

tert-Butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 98%, 500mg

2-Heptadecylimidazole>85.0%(GC)500g

(S)-(2-Oxooxazolidin-4-yl)methyl 4-methylbenzenesulfonate, 98%, 100mg

6-AMINO-4-METHYLPYRIDIN-3-OL, 95%, 1g

Trimethoxy(1H,1H,2H,2H-tridecafluoro-n-octyl)silane>97.0%(GC)25g

3-Methyl-4-((E)-4-phenyl-but-3-enyl)-piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

2-Amino-2',4-dichlorodiphenyl Ether>98.0%(GC)(T)5g

Potassium ((4-(tert-butoxycarbonyl)piperazin-1-yl)methyl)trifluoroborate, 95.0%, 250mg

ROTI® SampleLyse Soft Tissue 4, 250 pcs 250 pcs

1-[2-(1H-pyrazol-1-ylmethyl)phenyl]methanamine, 95.0%, 5g